AzTrials
AzTrials

Ischemic StrokeNCT07793682

Early Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke

A study testing Computerized neuropsychological rehabilitation, Family psychoeducational program and Written information leaflet in people with Ischemic Stroke and Cognitive Impairment, run by Althaia Xarxa Assistencial Universitària de Manresa at 1 site in Spain.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Cognitive impairment and reduced quality of life are frequent consequences of ischemic stroke and can also affect family caregivers, who often assume caregiving responsibilities with limited preparation. Evidence regarding rehabilitation interventions initiated during the early poststroke period remains limited. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Computerized neuropsychological rehabilitation, Family psychoeducational program and Written information leaflet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
81 participants
Where
1 siteSpain
Study dates
19 Nov 2025to 27 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First-ever ischemic stroke, excluding transient ischemic attack
  • Age 18 years or older
  • Functional independence before the index stroke, defined as a prestroke Modified Rankin Scale score ≤1
  • Diagnosis of ischemic stroke classified according to the Oxfordshire Community Stroke Project as total anterior circulation infarction, partial anterior circulation infarction, posterior circulation infarction, or lacunar infarction
  • Capacity to provide written informed consent at enrollment or, in cases of temporary incapacity, availability of a legally authorized representative to provide consent on the participant's behalf, followed by participant re-consent if decision-making capacity is regained

Who cannot join

  • Previous neurological or psychiatric disease associated with cognitive impairment
  • Severe systemic disease
  • Life expectancy of less than 1 year
  • Severe stroke, defined as a National Institutes of Health Stroke Scale score >19 at admission
  • Alcohol or other substance abuse, excluding tobacco use
  • Clinically relevant aphasia preventing comprehension of neuropsychological test instructions, operationalized as a score <5 on the fluency subscale of the Western Aphasia Battery
  • Sensory impairment preventing valid neuropsychological assessment or use of the intervention materials, such as severe visual or hearing impairment
  • Functional illiteracy, defined as inability to read and understand simple written instructions

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitari Sant Joan de Déu de Manresa, Fundació Althaia

    Manresa, Barcelona, 08243

Other trials in Spain

About this study

Official title: Efficacy of Early Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke: A Randomized 2×2 Factorial Clinical Trial With Blinded Outcome Assessment

Cognitive impairment and reduced quality of life are frequent consequences of ischemic stroke and can also affect family caregivers, who often assume caregiving responsibilities with limited preparation. Evidence regarding rehabilitation interventions initiated during the early poststroke period remains limited.

This randomized clinical trial evaluates two independent interventions initiated after baseline assessment and randomization, approximately 20 days after the index stroke: a structured computerized neuropsychological rehabilitation program for the patient and a structured psychoeducational program for the primary family caregiver. A 2×2 factorial design allows the main effect of each intervention to be estimated within a single sample and permits an exploratory assessment of their interaction.

The primary outcome is quality of life at 3 months after stroke, measured using the CAVIDACE total direct score and completed by a family informant. Secondary outcomes include cognitive performance, functional status, mood, and caregiver burden. Molecular biomarkers and acute structural neuroimaging variables are examined as exploratory outcomes.

Read the detailed description

Background and rationale

Cognitive deficits are frequent after ischemic stroke and may adversely affect functional recovery, quality of life, emotional well-being, and participation in rehabilitation. Although recovery trajectories vary considerably between individuals, the early poststroke period represents an important phase of cognitive, functional, and psychosocial adaptation. Evidence regarding structured cognitive rehabilitation initiated during this early period remains limited.

Stroke also has important consequences for family members and informal caregivers. Caregivers may experience substantial burden associated with functional dependence, cognitive and behavioral changes, emotional difficulties, and the demands of providing ongoing support. Structured psychoeducational interventions may help caregivers understand the consequences of stroke and develop appropriate strategies for supporting recovery and adaptation.

This trial evaluates both dimensions simultaneously by examining computerized neuropsychological rehabilitation directed at the patient and structured family psychoeducation directed at the primary family caregiver.

Procedures

Participants are recruited during the acute phase of ischemic stroke, within 96 hours of symptom onset. Baseline assessment of the primary outcome is performed approximately 20 days after the index stroke, before randomization and before either intervention begins. Randomization is performed after completion of this baseline assessment.

Allocation is stratified according to receipt of acute reperfusion therapy, defined as intravenous thrombolysis and/or mechanical thrombectomy versus no reperfusion treatment. Reperfusion status is used as a prespecified prognostic stratification factor. Randomization is implemented through the REDCap electronic data capture system using randomly permuted blocks of variable size. The allocation sequence is inaccessible to personnel responsible for recruitment and eligibility assessment, and the next treatment assignment cannot be anticipated.

Both intervention factors begin after randomization, approximately 20 days after the index stroke, and continue for approximately 12 weeks. The primary outcome assessment is scheduled at 3 months after stroke, corresponding to 90 days ±14 days. An optional 12-month follow-up constitutes an observational extension and is not part of the primary randomized trial analysis.

Participants allocated to computerized neuropsychological rehabilitation receive 24 sessions of structured computerized cognitive training using the Guttmann NeuroPersonalTrainer platform. Sessions last 45 minutes and are delivered twice weekly over approximately 12 weeks. The sequence and duration of the cognitive exercises are standardized, while task difficulty is individually adjusted by the platform according to previous performance. The intervention targets attention, processing speed, memory, executive functions, language, visuospatial abilities, and functional transfer of trained strategies.

Participants not allocated to computerized neuropsychological rehabilitation receive an active digital control condition consisting of simple recreational digital activities matched in duration and frequency. These activities do not incorporate adaptive difficulty, structured therapeutic progression, or cognitive performance feedback.

Primary family caregivers allocated to structured family psychoeducation receive six individual 45-minute sessions delivered by videoconference approximately every 2 weeks over 12 weeks. The program includes stroke education, the role of the family in recovery, emotional management, behavioral difficulties, cognitive restructuring, relaxation, self-compassion, mindfulness-based coping strategies, and behavioral activation. Caregivers are not trained in cognitive rehabilitation techniques in order to preserve the conceptual independence of the two factorial intervention components.

Primary family caregivers not allocated to structured psychoeducation receive a brief informational leaflet at the approximately 20-day visit after randomization. The leaflet provides general information about stroke and its physical, communicative, cognitive, emotional, and behavioral consequences, together with recommended educational resources. It does not include behavioral management strategies, structured psychoeducational techniques, or cognitive rehabilitation training.

All participants continue to receive usual poststroke clinical care. Physiotherapy, occupational therapy, speech therapy, convalescence care, and other rehabilitation services may be prescribed according to clinical indication and are recorded as co-interventions.

Outcomes and analysis

The primary outcome is the CAVIDACE total direct score at 3 months after stroke, completed by a family informant. The total direct score ranges from 0 to 192, with higher scores indicating better quality of life. The corresponding CAVIDACE score obtained approximately 20 days after stroke is used as the baseline covariate in the primary analysis.

Secondary outcomes are organized into two independent prespecified families. The family associated with computerized neuropsychological rehabilitation includes the global neuropsychological composite score, Modified Rankin Scale, Barthel Index, and Lawton-Brody Instrumental Activities of Daily Living Scale. The family associated with structured family psychoeducation includes the Zarit Burden Interview, Hospital Anxiety and Depression Scale Anxiety subscale, Hospital Anxiety and Depression Scale Depression subscale, and Beck Depression Inventory-II.

The primary analysis follows the intention-to-treat principle and uses an analysis of covariance model including the main effects of both intervention factors, baseline CAVIDACE, and the randomization stratum. The F1×F2 interaction is examined in a separate exploratory model.

Exploratory biological outcomes include brain-derived neurotrophic factor, glial fibrillary acidic protein, interleukin-6, C-reactive protein, and S100 calcium-binding protein B. Acute structural magnetic resonance imaging variables include lesion volume, lesion location, vascular territory, Oxfordshire Community Stroke Project classification, and apparent diffusion coefficient. These analyses are considered exploratory and hypothesis-generating.

A prespecified Statistical Analysis Plan defining the estimands, analysis models, handling of missing data, multiplicity, and sensitivity analyses was finalized and signed before database lock and before any comparative analysis of study outcomes.

Being tested
Computerized neuropsychological rehabilitation, Family psychoeducational program, Non-specific recreational cognitive activities / active digital control, Written information leaflet
Keywords
stroke rehabilitation, neuropsychological rehabilitation, psychoeducation, caregiver, factorial design, acute phase
Medical subject headings
Ischemic Stroke, Cognitive Dysfunction, Caregiver Burden

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Computerized neuropsychological rehabilitationBehavioural

    Structured computerized cognitive training using the Guttmann NeuroPersonalTrainer platform. The intervention comprises 24 sessions of 45 minutes, delivered twice weekly over approximately 12 weeks, starting after randomization approximately 20 days after the index stroke. The sequence and duration of cognitive exercises are standardized, while task difficulty is individually adjusted by the platform according to previous performance.

  • Family psychoeducational programBehavioural

    Six individual 45-minute sessions delivered by videoconference to the primary family caregiver approximately every 2 weeks over 12 weeks. The program covers stroke education, the role of the family in recovery, emotional management, behavioral difficulties, cognitive restructuring, relaxation, self-compassion, mindfulness-based coping strategies, and behavioral activation. Caregivers are not trained in cognitive rehabilitation techniques.

  • Non-specific recreational cognitive activities / active digital controlOther

    Simple recreational digital activities matched to the computerized neuropsychological rehabilitation condition in session duration and frequency. The activities do not incorporate adaptive difficulty, structured therapeutic progression, or cognitive performance feedback.

  • Written information leafletOther

    A brief informational leaflet provided at the approximately 20-day visit after randomization. The leaflet includes general information about stroke and its physical, communicative, cognitive, emotional, and behavioral consequences, together with recommended educational resources. It does not include behavioral management strategies, structured psychoeducational techniques, or cognitive rehabilitation training.

Study groups in NCT07793682
Study groupRoleWhat they receive
Group 1: ControlActive comparatorNot described
Receives: Other: Non-specific recreational cognitive activities / active digital control; Other: Written information leaflet
Group 2: Neuropsychological rehabilitationExperimentalNot described
Receives: Behavioral: Computerized neuropsychological rehabilitation; Other: Written information leaflet
Group 3: Family psychoeducationExperimentalNot described
Receives: Behavioral: Family psychoeducational program; Other: Non-specific recreational cognitive activities / active digital control
Group 4: Combined interventionExperimentalNot described
Receives: Behavioral: Computerized neuropsychological rehabilitation; Behavioral: Family psychoeducational program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of life (CAVIDACE total direct score)

    The CAVIDACE scale (Quality of Life in Acquired Brain Injury) is completed by a family informant. The total direct score ranges from 0 to 192, with higher scores indicating better quality of life. The corresponding CAVIDACE score obtained approximately 20 days after stroke is used as the baseline covariate in the primary analysis.

    Measured: 3 months post-stroke (day 90 ± 14 days)

Secondary outcomes (8)
  1. Global neuropsychological composite score

    The global neuropsychological composite score is calculated as the unweighted mean of standardized z scores across five cognitive domains: attention and processing speed, memory and learning, language, executive functioning, and visuospatial functioning. Individual neuropsychological test scores are standardized using the corresponding normative data. At least three valid cognitive-domain scores are required to calculate the composite. Because the composite consists of standardized z scores, it has no fixed theoretical minimum or maximum. Higher scores indicate better global cognitive performance.

    Measured: 3 months post-stroke (90 days ±14 days)

  2. Modified Rankin Scale

    The Modified Rankin Scale assesses global disability after stroke on an ordinal scale ranging from 0 to 6. A score of 0 indicates no symptoms, whereas a score of 6 indicates death. Higher scores indicate greater disability and a worse outcome.

    Measured: 3 months post-stroke (90 days ±14 days)

  3. Barthel Index

    The Barthel Index assesses independence in basic activities of daily living. The total score ranges from 0 to 100. Higher scores indicate greater functional independence and a better outcome.

    Measured: 3 months post-stroke (90 days ±14 days)

  4. Lawton-Brody Instrumental Activities of Daily Living Scale

    The Lawton-Brody Instrumental Activities of Daily Living Scale assesses independence in instrumental activities of daily living. The 8-item version used in this study ranges from 0 to 8. Higher scores indicate greater independence and a better functional outcome.

    Measured: 3 months post-stroke (90 days ±14 days)

  5. Zarit Burden Interview, 22-item version

    The 22-item Zarit Burden Interview assesses perceived caregiver burden. Each item is rated from 0 to 4, yielding a total score ranging from 0 to 88. Higher scores indicate greater perceived caregiver burden and a worse outcome.

    Measured: 3 months post-stroke (90 days ±14 days)

  6. Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A)

    The Hospital Anxiety and Depression Scale Anxiety subscale consists of 7 items and yields a total score ranging from 0 to 21. Higher scores indicate greater severity of anxiety symptoms and a worse outcome.

    Measured: 3 months post-stroke (90 days ±14 days)

  7. Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D)

    The Hospital Anxiety and Depression Scale Depression subscale consists of 7 items and yields a total score ranging from 0 to 21. Higher scores indicate greater severity of depressive symptoms and a worse outcome.

    Measured: 3 months post-stroke (90 days ±14 days)

  8. Beck Depression Inventory-II

    The Beck Depression Inventory-II consists of 21 items and yields a total score ranging from 0 to 63. Higher scores indicate greater severity of depressive symptoms and a worse outcome.

    Measured: 3 months post-stroke (90 days ±14 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2026
  2. Study start19 Nov 2025
  3. Primary completion25 Nov 2026 (estimated)
  4. Study completion27 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
81 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07793682
Sponsor's protocol ID
CER-21-39
Status last verified
Aug 2026
First submitted
26 Aug 2026
Last updated
3 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Following publication of the primary trial results, deidentified individual participant data underlying the published analyses, together with the corresponding data dictionary where applicable, may be made available upon reasonable request. Access will be subject to approval by Fundació Althaia and compliance with applicable ethical, institutional, informed-consent, and data-protection requirements.

Questions about this trial

What is this clinical trial studying?

A study testing Computerized neuropsychological rehabilitation, Family psychoeducational program and Written information leaflet in people with Ischemic Stroke and Cognitive Impairment, run by Althaia Xarxa Assistencial Universitària de Manresa at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of life (CAVIDACE total direct score) (time frame: 3 months post-stroke (day 90 ± 14 days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in